Alberta Investment Management Corporation »

Ultragenyx Pharmaceutical shares owned by Alberta Investment Management Corporation

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Alberta Investment Management Corporation from 13F filings

Historical chart of Alberta Investment Management Corporation investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Alberta Investment Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Alberta Investment Management Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $883k 38k 23.00

More positions owned by Alberta Investment Management Corporation

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Western Digital Corp Note 3.000%11/1 (Principal)
Agnico (AEM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Bank Of Montreal Cadcom (BMO)
Interdigital Note 3.500% 6/0 (Principal)
Bk Nova Cad (BNS)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)

View all positions for Alberta Investment Management Corporation

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
FMR
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Sands Capital Management
Rtw Investments
Baker Bros. Advisors
Suvretta Capital Management
Frontier Capital Management
Wellington Management Company
Bnp Paribas Investment Partners
Geode Capital Management
Jacobs Levy Equity Management
Standard Life Aberdeen

View all funds holding Ultragenyx Pharmaceutical